Description
Ponatinix 45mg (Ponatinib)
This medicine is used for treating certain types of chronic myeloid leukaemia. It falls in the class of multi-targeted tyrosine-kinase inhibitors. It is very effective against T315I mutation for the treatment of chronic myeloid leukaemia. The generic name for this medicine is ponatinib. Beacon pharmaceutical LTD. is the manufacturer and distributor of this medicine.
Dosages
The recommended starting dosage for Ponatinix 45mg is 45 mg orally once daily. You can take it with or without the food. You need to swallow the whole tablet.
Side Effects
inflammation of the pancreas
Bladder pain
increased risk of stroke.
dizziness
heart problems.
Fainting
Storage
You need to Store this at 20-25ºC (68-77ºF); the excursion limit is permitted to 15-30ºC (59-86ºF). Keep this away from moisture and direct sunlight.
Reviews
There are no reviews yet.